Package Leaflet: Information for the User
itraconazol cinfa 100 mg hard capsules EFG
Read this leaflet carefully before you start to take this medicine because it contains important information for you.
Itraconazol belongs to a group of medicines called “antifungals”.
It is indicated for the treatment of infections caused by fungi of the vagina, skin, mouth, eyes, nails, or internal organs.
Do not take itraconazole cinfa:
If your doctor thinks you should take this medicine, contact him immediately if you notice that you are short of breath, gain weight unexpectedly, have swollen legs, feel unusually tired, or start waking up at night.
Inform your doctor if you are taking any other medicine.
Do not use itraconazole ifyou are taking any of the following medicines, or within 2 weeks of the end of itraconazole:
Medicines used to treat heart, blood, or circulation problems:
Medicines to treat stomach or constipation problems:
Medicines to treat headache, sleep, or mental health problems:
Medicines to treat urinary problems:
Medicines to treat allergies:
Medicines to treat erection and ejaculation problems:
Other medicines that contain:
Remember: do not take any of the above medicines during 2 weeks after your last treatment with itraconazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take itraconazole cinfa:
Other medicines and itraconazole cinfa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including those purchased without a prescription.
There are medicines thatshould not be takenwhile taking itraconazole. These medicines are listed above under the heading“Do not take itraconazole cinfa”.
It is not recommended to use certain medicines with itraconazole.
Your doctor may decide thatyou should not take some medicines at the same time as itraconazole or within 2 weeks after its completion.
Examples of these medicines are:
Medicines used to treat heart, blood, or circulation problems:
Medicines to treat epilepsy, headaches, or mental health problems:
Medicines to treat urinary problems:
Medicines to treat cancer:
Medicines to treat tuberculosis:
Medicines to treat HIV or hepatitis:
Medicines used after organ transplantation:
Medicines to treat benign prostatic hyperplasia:
Medicines to treat respiratory, allergy, or inflammatory problems:
Medicines to treat erection and ejaculation problems:
Medicines to treat pain:
Other medicines that contain:
This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines or any other medicine.
You should be careful when using itraconazole with certain medicines.It is possible that you may be more likely to experience side effects or that the dose of itraconazole or the other medicine may need to be adjusted. Examples of these medicines are:
Medicines used to treat heart, blood, or circulation problems:
Medicines to treat stomach or diarrhea problems:
Medicines to treat sleep or mental health problems:
Medicines to treat urinary problems:
Medicines to treat cancer:
Medicines to treat infections:
Medicines to treat HIV or hepatitis:
Medicines used after organ transplantation:
Medicines to treat benign prostatic hyperplasia:
Medicines to treat respiratory, allergy, or inflammatory problems:
Medicines to treat erection and ejaculation problems:
Medicines to treat pain:
Other medicines that contain:
This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines, or any other medicine, so that appropriate measures can be taken.
You should have enough acidity in the stomach to ensure the absorption of this medicine. Therefore, medicines that neutralize stomach acid should be taken at least 2 hours before taking itraconazole or 2 hours after taking it. For the same reason, if you are taking medicines that regulate stomach acid production, take itraconazole with a cola drink (see section 3 “How to take itraconazole cinfa”).
If in doubt, consult your doctor or pharmacist.
Taking itraconazole cinfa with food and drinks
Take this medicine immediately after finishing one of the main meals. If you are taking any medicine that regulates stomach acid production, it is recommended to take this medicine with a cola drink.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or could become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Consult your doctor or pharmacist before using any medicine.
This medicine will not be used during pregnancy.
If you are fertile and may become pregnant, consult your doctor. You should use effective contraceptive measures to avoid becoming pregnant while taking the medicine. Because this medicine may remain in the body for some time, you should prolong contraceptive measures until the next menstrual period after completing treatment with this medicine (see section 2 “Do not take itraconazole cinfa”).
Breastfeeding
Consult your doctor or pharmacist before using any medicine.
If you are breastfeeding, consult your doctor before taking itraconazole, as small amounts of the medicine may appear in milk.
Driving and operating machinery
Itraconazole may cause dizziness, blurred vision, or hearing loss. If you experience any of these symptoms, do not drive or operate machinery.
itraconazole cinfa contains saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.
Remember to take your medication.
Your doctor will indicate the duration of your treatment with this medication. Do not stop treatment before. If you estimate that the medication's action is too strong or too weak, inform your doctor or pharmacist.
You must take this medication immediately after meals, as it is absorbed better. Swallow the capsules whole with a little water. The number of capsules you should take and for how long depends on the type of fungus and the location of the infection. Your doctor will tell you exactly how much itraconazole you should take.
There must be enough acidity in the stomach to ensure the absorption of this medication. Therefore, medications that neutralize stomach acidity should be used two hours after taking this medication or two hours before taking itraconazole. For the same reason, if you are taking medications that regulate acid production in the stomach, take itraconazole with a cola drink.
The following doses are the most frequent:
TYPE OF INFECTION | CAPSULES PER DAY | DURATION |
Vaginal infection | 2 capsules twice a day or 2 capsules once a day | 1 day 3 days |
Skin infection | 2 capsules once a day or 1 capsule once a day | 7 days 2 weeks |
If the palms of the hands or the soles of the feet are affected, 2 capsules twice a day for 7 days or 1 capsule once a day for 1 month may be needed. | ||
Mouth infections | 1 capsule once a day | 2 weeks |
Eye infections | 2 capsules once a day | 3 weeks |
Internal infections | 1 to 4 capsules daily | Longer periods |
TYPE OF INFECTION | CAPSULES PER DAY | DURATION |
Continuous treatment for nails | 2 capsules once a day | 3 months |
This consists of 2 capsules twice a day for 1 week; then stop taking itraconazole for 3 weeks. The cycle is then repeated, once for the hands and twice for the feet (with or without infection in the hands). (See the following table)
Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9 | Week 10 | |
Foot nails with or without hand nail involvement | Take 2 capsules twice a day | No treatment with Itraconazole | Take 2 capsules twice a day | No treatment with Itraconazole | Take 2 capsules twice a day | Stop treatment | ||||
Only hand nails | Take 2 capsules twice a day | No treatment with itraconazole | Take 2 capsules twice a day | Stop treatment |
For skin infections, lesions will disappear a few weeks after treatment is completed. This is characteristic of fungal spots: the medication eliminates the fungus itself, but the lesion does not disappear until new skin grows.
Nail lesions will disappear from 6 to 9 months after treatment is completed, as the medication only eliminates the fungus itself. The nail must grow, which takes several months. Therefore, do not worry if you do not notice improvement during treatment: the medication remains in your nails for several months and fulfills its mission. Therefore, you should interrupt treatment at the time your doctor indicates, even if you do not see any improvement.
Internal organ infections:Higher doses may be needed and for a long time.
Always follow your doctor's instructions, as he will adapt the treatment to your needs.
Use in children
This medication should not be used in children. It can only be prescribed by a doctor in exceptional cases.
If you take more itraconazole cinfa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
In case of accidental overdose, your doctor will apply supportive measures. Itraconazole is not eliminated by hemodialysis. No specific antidotes are known.
If you forgot to take itraconazole cinfa
If you forget to take the medication, take the next dose that corresponds to you and continue treatment as indicated by your doctor. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with itraconazole cinfa
Do not stop treatment with itraconazole without consulting your doctor, as the symptoms of your disease may reappear or worsen.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
If you consider that any of the side effects you are experiencing are serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
The following side effects have been seen during the marketing of the medicine and clinical trials.
Adverse reactions were classified by frequency using the following convention: Very common (may affect more than 1 in 10 people);
Common (may affect up to 1 in 10 people);
Uncommon (may affect up to 1 in 100 people);
Rare (may affect up to 1 in 1,000 people);
Very rare (may affect up to 1 in 10,000 people);
Frequency not known (cannot be estimated from available data).
Infections and infestations
Blood and lymphatic system disorders
Immune system disorders
Metabolism and nutrition disorders
Nervous system disorders
Eye disorders
Ear and labyrinth disorders
Cardiac disorders
Respiratory, thoracic and mediastinal disorders
Gastrointestinal disorders
Hepatobiliary disorders
Skin and subcutaneous tissue disorders
Renal and urinary disorders
Reproductive and breast disorders
General disorders and administration site conditions
Investigations
Description of certain side effects
The following side effects are associated with itraconazole and have been reported in clinical trials of itraconazole oral and/or intravenous solution, excluding the side effect "inflammation at the injection site" which is specific to the intravenous route.
Blood and lymphatic system disorders:granulocytopenia, thrombocytopenia (decreased platelet count).
Immune system disorders:anaphylactoid reaction.
Metabolism and nutrition disorders:hyperglycemia (elevated blood sugar), hyperkalemia (elevated potassium), hypokalemia (decreased potassium), hypomagnesemia (decreased magnesium).
Mental and behavioral disorders:sensation of confusion or disorientation.
Nervous system disorders:peripheral neuropathy (affecting peripheral nerves with a sensation of tingling, numbness, or weakness in the extremities), dizziness, somnolence.
Cardiac disorders:heart failure, left ventricular insufficiency, tachycardia (rapid heart rate).
Vascular disorders:hypertension (high blood pressure), hypotension (low blood pressure).
Respiratory, thoracic and mediastinal disorders:pulmonary edema, hoarseness, cough.
Gastrointestinal disorders:gastrointestinal disorder.
Hepatobiliary disorders:liver insufficiency, hepatitis, jaundice (yellowing of the skin, eyes, mucous membranes, and secretions).
Skin and subcutaneous tissue disorders:erythematous rash (exanthema eritematoso), excessive sweating.
Musculoskeletal and connective tissue disorders:muscle or joint pain (myalgia), joint pain (arthralgia).
Renal and urinary disorders:renal insufficiency, urinary incontinence (urine loss).
General disorders and administration site conditions:generalized edema (fluid accumulation in the body tissues), facial edema, chest pain, fever, pain, fatigue, chills.
Investigations:increased alanine aminotransferase, increased aspartate aminotransferase, increased alkaline phosphatase in the blood, increased lactate dehydrogenase in the blood, increased urea in the blood, increased gamma-glutamyltransferase, increased liver enzymes, abnormal urine analysis.
Other side effects in children
Based on data from pediatric clinical trials, the most frequently reported side effects were: headache, vomiting, abdominal pain, diarrhea, abnormal liver function, low blood pressure, nausea, and urticaria.
In general, the nature of the side effects is similar to that observed in adult patients, although the incidence is higher in pediatric patients.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of itraconazole cinfa
Contents of the capsule: sugar spheres (containing saccharose, cornstarch and purified water), poloxamer 188 and hypromellose.
Capsule coating: gelatin, purified water, blue FD & C2, indigotin, cochineal extract (E-132), quinoline yellow (E-104) and titanium dioxide (E-171).
Appearance of the product and contents of the packaging
Hard gelatin capsules, with green opaque cap and body, containing beige-yellow microspheres.
It is presented in Aluminio/Aluminio blisters. Each package contains 7, 14 or 100 (clinical package) capsules.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) - Spain
Responsible manufacturer:
LICONSA, S.A.
Avda. Miralcampo, Nº 7 Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara), Spain
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) - Spain
Last review date of this leaflet: July 2021
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/65773/P_65773.html
QR code to: https://cima.aemps.es/cima/dochtml/p/65773/P_65773.html
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.